Catalyst
Slingshot members are tracking this event:
Immune Design (IMDZ) to present data set for G100 Merkel cell carcinoma Phase 1 study at ASCO 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IMDZ |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 20, 2016
Occurred Source:
https://am.asco.org/abstracts
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Merkel Cell Carcinoma, Phase 1 Data, G100, Asco 2016, Interim Data
